Piramal Group

Piramal Group, established in 1947, stands as a prominent global business conglomerate with extensive interests spanning pharmaceuticals, financial services, and real estate. With a robust operational footprint encompassing 16 international locations, the organization currently supports a workforce of 10,000+ employees. The company distinguishes itself by deploying a sophisticated, proprietary technology platform driven by artificial intelligence, which facilitates innovative financial and operational solutions across diverse industry verticals.

The firm’s pharmaceutical division provides comprehensive end-to-end contract development and manufacturing services, specializing in complex drug life cycle management, anesthesia, and pain management therapies. Simultaneously, its financial services arm delivers integrated platforms for retail and wholesale lending, supported by fund-based structures. By leveraging advanced data analytics and specialized information services, Piramal Group maintains a significant competitive advantage within the global healthcare and financial sectors, ensuring high-quality service delivery for its international client base.

Piramal Group continues to strengthen its market position through strategic private equity partnerships, including substantial capital infusions from major investors like The Carlyle Group. Meet Piramal Group's team to gain insights into the leadership and organizational structure driving these complex, multi-sector operations. Furthermore, stakeholders can Explore financial highlights to review the company's $1.2B annual revenue performance and fiscal stability. The group remains a pivotal player in the global business landscape, consistently integrating cutting-edge technology to optimize its service delivery and operational efficiency across all business units.